China Fishery, an industrial fishing company part-owned by The Carlyle Group, will pay $555.8 million for Peruvian counterpart Copeinca. The acquisition will make China Fishery the largest player in the world’s largest market by volume for fishmeal and fish oil exports.
The company has offered NOK3.85 per share in cash for all outstanding shares in Oslo-listed Copeinca, which represents a premium of 21.6% to the company's closing price on February 25. China Fishing has...
Even if pan-Asian buyout firms aren't actively pursuing investments in internet-related businesses, they cannot ignore the potential disruptive impact of these technologies on other portfolio companies
Mekong Capital's 6.3x return on its investment in Vietnam-based pharmaceuticals player Traphaco involved turning the company's distribution model on its head, as well as supporting expansion and improving governance
China Renaissance has added dedicated healthcare and mezzanine debt strategies to its existing growth-stage private equity offering as part of efforts to more than treble its assets under management (AUM) over the next three years.
China Venture Capital Fund, a VC vehicle backed by the Chinese government, and ChinaEquity Group have jointly led a RMB670 million ($101 million) round for 3D Medicines, which focuses on personalized diagnostics and treatment for cancer.